SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
Quest Diagnostics Inc.
DGX
|
|
|
+5.00%
in
156 days
Top Stock 4 – Quest Diagnostics ( DGX ) An aging population and a greater emphasis on preventative care are creating a high-growth opportunity for Quest Diagnostics ( DGX ). This company is the leading provider of independent diagnostic testing in the U.S. It has built a network of more than 2,000 patient service centers across the country, offering its customers a wide array of routine and specialty laboratory tests and services. <> DGX posted a nearly 25% jump in earnings for the first quarter and a significant uptick in sales that beat expectations. These are very soli...
|
Obama-Care Focused on Preventive Medicine
DGX
|
|
|
+26.51%
in
395 days
<> 
In addition to bullish outlooks for generic drugs and Health IT , President-Elect Obama's healthcare plan plans to focus on public health initiatives and mandated coverage of preventive services such as cancer screenings. The accompanying table presents statistics and the top five rated companies in the ETFI Preventive Medicine Index, including vaccine makers such as Emergent BioSolutions (EBS), diabetes care companies such as Novo Nordisk (NVO), diagnostic companies such as Sequenom (SQNM) and Myriad Geneti...
|
A Defensive Growth Stock Index
DGX
|
|
|
+2.13%
in
16 days
(closed on 11/05/08)
<> 
<> The accompanying table presents the ETFI Highly Defensive PerformIdex, which is structured as a market cap weighted, defensive growth index of 30 companies based in either the United States or Canada with the largest market capitalizations from each industry group (A-J) as specified below:
(A) Grocery Stores (1)
(B) Consumer Staples (10) – Non-Food (2), Food (4), Tobacco (1), Alcoholic Beverages (1), and Non-Alcoholic Beverages (2)
(C) Health Benefit Providers (3) – Managed Healthcare (1), Supplemental Health (1), an< />< />< />< />< />< />< />< />< />...
|
Under Valued
DGX
|
|
|
-1.05%
in
12 minutes
(closed on 10/06/08)
Quest is a solid company with a stock value that doesn't match its potential... Besides recently going international in India... Quest has time and time again beaten predicted earning marks... recently reporting a 14% higher earnings report then predicted... Unless people plan on not having babies and doctors decide lab testing is obsolete... this company will grow and continue on its upward path...
|
DGX is a HOLD
DGX
From the Blogosphere
Quest Diagnostics: Pull-back is Buy opportunity
Filed under: Products and services, Recession The nation is on the cusp of historic and civilization-advancing change with the upcoming health care reform bill, and that change bodes well for Quest Diagnostics (NYSE: DGX), which is why I'm reiterating my Buy rating for the company, first recommended on June 25, 2009, at a price of $55.89. <>Quest's positive story remains the same: diagnostic tests are at the core of health care services, and even though the number of tests per citizen will likely decline in the years ahead, when one adds 30-45 million more citizens regularly accessing health ca...
|
Genoptix Inc. (GXDX) Adding Physicians and Growing Revenue
|
|
|
 Health Care has been a controversial topic for US investors. Reforms to Medicare and regulations on private insurers will likely have an industry altering effect. There have certainly been some land mines to dodge when investing in this sector, but profitable positions have also been available. Take for instance Amedisys Inc. (AMED) which is up about 33% since the stock was recommended in here in April. Amedisys is positioned to actually save Medicare costs and investors are bidding the stock higher in anticipation of the strength.
<form><input /><input /><input /><input /><input />...
|
Quest Diagnostics is well-positioned in a preferred sector
Investments in Healthcare - A Defensive Approach
|
|
|
 We’ve had quite a spring rally in the last two months. It’s hard to believe that the S&P 500 has rallied as much as 40% since the panic levels in March, and many individual issues have given investors chances to double or triple their money in just a few short weeks. We are now beginning to hear whispers of economic recovery and new bull markets. (Actually, by definition, this latest rally constitutes a bull market because it exceeds a 20% gain - but don’t try to explain that to investors who are still 41% below the October 2007 high).
<form>Other Articles of Interest
<><><> Obama’s Bu< /><><><>< /><><><>< /><><><><><><><><><><><><><><><><><><><><><><><><>< /><><><><><><><><><><><><>< /><><><><><><><><><><><>< /><><><><><><><><><><><><><>< /><><><>< /><><><>< /><>< /><><>< /><>< />< />...
|
Analyst upgrades, downgrades and initiations: TASR, M, FDO, NVDA, DGX ...
 Analyst upgrades:
<> Merriman upgraded Taser (NASDAQ: TASR) to Buy from Neutral as it believes current valuation levels do not reflect the company's market opportunities and that the law enforcement funding in President Obama's stimulus plan will boost sales in Q4 and FY10.
Goldman upgraded Macy's (NYSE: M) to Buy from Neutral and added shares to its Conviction Buy List based on reduced balance sheet concerns and improved risk/reward. The firm also raised their target to $8.25 from $8.
<>JP Morgan upgraded Family Dollar (NYSE: FDO) to Neutral from Underweight and raised its target to ...
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
Visit streetinsider.com
Be the first to start a discussion and earn 2 points.
More Resources
|
About Quest Diagnostics Inc.
- Answers.com
